Children Born Preterm: Sustainable Health Monitoring

NCT ID: NCT06270368

Last Updated: 2024-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

650 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-05

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children born preterm are recognized to be at higher risk of short and long term complications and a formal follow-up of infants and children born preterm is recommended by international and national scientific societies. However, in Italy as well as in Tuscany, such a follow up is not usually done, and data are not collected in a structured way. The goal of this observational study is to evaluate the association between a large number of early life exposures and health outcomes and access to care during childhood in infants born preterm. The main questions it aims to answer are: • what is the role of prenatal and perinatal factors in influencing health outcomes during childhood in preterm infants? • What is the role of prenatal and perinatal factors in influencing access to care during childhood? Participants will be asked to attend a follow-up visit for the purpose of collecting health data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children born preterm (gestational age below 37 weeks at birth) in Tuscany Region
* Acquisition of the informed consent

Exclusion Criteria

* Residing outside Tuscany region
Minimum Eligible Age

20 Months

Maximum Eligible Age

66 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Fondazione Stella Maris

OTHER

Sponsor Role collaborator

Meyer Children's Hospital IRCCS

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vieri Lastrucci

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vieri Lastrucci, MD

Role: PRINCIPAL_INVESTIGATOR

Meyer Children's Hospital IRCCS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda Ospedaliero-Universitaria Careggi (AOUC)

Florence, , Italy

Site Status RECRUITING

Meyer Children's Hospital IRCCS

Florence, , Italy

Site Status RECRUITING

Azienda Ospedaliero Universitaria Pisana (AOUP)

Pisa, , Italy

Site Status RECRUITING

Azienda Ospedaliero Universitaria Senese (AOUS)

Siena, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vieri Lastrucci

Role: CONTACT

+393297487648

Elettra Berti

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Simone Pratesi

Role: primary

Vieri Lastrucci

Role: primary

Rosa Scaramuzzo

Role: primary

Carlo Valerio Bellieni

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PREHMO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.